Navigate this market better. Subscribe for FREE stock alerts and information.

Thursday, February 5, 2015

Pfizer to purchase Hospira for about $15 bln, (NYSE: HSP), (NYSE: PFE)

Drugmaker Pfizer Inc said it would purchase Hospira Inc for about $15 billion to gain access to its biosimilars. The offer of $90 per share represents a premium of 39 percent to Hospira stock's close on Wednesday.

Hospira, Inc. (Hospira) is a provider of injectable drugs and infusion technologies. Shares of HSP traded higher by 1.73% or $1.1/share to $64.80. In the past year, the shares have traded as low as $40.41 and as high as $66.56. On average, 1017200 shares of HSP exchange hands on a given day and today's volume is recorded at 1099024.

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. Shares of PFE traded higher by 1.04% or $0.33/share to $32.07. In the past year, the shares have traded as low as $27.51 and as high as $33.50. On average, 25562300 shares of PFE exchange hands on a given day and today's volume is recorded at 36706660.



Source